Ketorolac Tromethamine Injection, Solution
Product Images NDC 63323-161

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 63323-161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Ket0m 0006 01)

Chemical structure of Ketorolac Tromethamine showing the molecular components of the active ingredient. The diagram depicts the arrangement of atoms and bonds specific to ketorolac combined with tromethamine.*

FDA Label Image

Figure (Ket0m 0006 02)

FDA Label Image

Figure (Ket0m 0006 03)

Label panel for Ketorolac Tromethamine injection, solution from Fresenius Kabi USA, LLC, including company address in Lake Zurich, IL. The label provides contact information and a website for more product details.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Ketorolac Tromethamine 1 mL Vial Label)

Label for Ketorolac Tromethamine Injection, USP 30 mg per mL, a single-dose vial for intramuscular or intravenous use. The label shows the product name, strength, route of administration, and indicates it is prescription only. The labeler is Fresenius Kabi USA, LLC.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Label for Ketorolac Tromethamine Injection, USP, 30 mg per mL, a solution for intramuscular or intravenous use. The 1 mL single dose vial label shows the NDC 63323-162-11 and is produced by Fresenius Kabi USA, LLC. It instructs to see the package insert for usual dosage and is Rx only.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Ketorolac Tromethamine Injection, USP 30 mg per mL in a 25 x 1 mL single dose vials pack. The label indicates use for intramuscular or intravenous administration. The product is sterile and includes storage instructions for controlled room temperature. Labeler is Fresenius Kabi USA, LLC.*

FDA Label Image

160101 Vial (Ket0m 0006 07)

Label for Ketorolac Tromethamine Injection, USP, 15 mg per mL strength, for intramuscular or intravenous use. The label indicates a 1 mL single dose vial and is labeled for prescription use only. Labeler is Fresenius Kabi USA, LLC.*

FDA Label Image

160101 Vial (Ket0m 0006 08)

Label for Ketorolac Tromethamine Injection, USP 15 mg per mL, a solution for intramuscular or intravenous use. The label indicates a 1 mL single dose vial, manufactured by Fresenius Kabi USA, LLC, with the NDC 63323-161-00. It advises to see the package insert for usual dosage and notes the product is prescription only.*

FDA Label Image

Tray (Ket0m 0006 09)

Label for Ketorolac Tromethamine Injection, USP 15 mg per mL in single-dose 1 mL vials. The product is intended for intramuscular or intravenous use. It is sterile and listed with Fresenius Kabi USA, LLC as the labeler, with storage instructions and a barcode also visible on the label.*

FDA Label Image

160201 Vial (Ket0m 0006 10)

Label for Ketorolac Tromethamine Injection, USP 30 mg per mL in a 1 mL single dose vial. The product is indicated for intramuscular or intravenous use, with dosage instructions referring to the package insert. The label includes the NDC 63323-162-00 and is from Fresenius Kabi USA, LLC.*

FDA Label Image

160201 Vial (Ket0m 0006 11)

Label for Ketorolac Tromethamine Injection, USP 30 mg per mL by Fresenius Kabi USA, LLC. The vial contains 1 mL single-dose solution intended for intramuscular or intravenous use, with instructions to see the package insert for usual dosage. The label includes NDC 63323-162-00 and states Rx only.*

FDA Label Image

Tray (Ket0m 0006 12)

Label for Ketorolac Tromethamine Injection, USP, 30 mg per mL, single-dose vials for intramuscular or intravenous use. The package contains 25 x 1 mL vials. Manufactured by Fresenius Kabi USA, LLC. The label includes sterile product information, storage conditions, and a barcode.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Ketorolac Tromethamine 2 mL Single Dose Vial Label)

Ketorolac Tromethamine Injection, USP 60 mg per 2 mL (30 mg per mL) single-dose vial label. The product is for intramuscular use only and not for intravenous use. It is supplied by Fresenius Kabi USA, LLC and is Rx only.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Ketorolac Tromethamine 2 mL Single Dose Vial Label)

Label for Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL strength (30 mg per mL). The label indicates it is for intramuscular use only, not for intravenous use, and is supplied as a 2 mL single dose vial. The labeler is Fresenius Kabi USA, LLC.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Ketorolac Tromethamine 2 mL Single Dose Vial Tray Label)

Label for Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), provided as single dose vials of 2 mL, packaged 25 vials per carton. Intended for intramuscular use only, not for intravenous use. Manufactured by Fresenius Kabi USA, LLC. Contains 30 mg ketorolac tromethamine per mL, with other ingredients including alcohol, sodium chloride, and citric acid. Storage conditions specify 20° to 25°C and protection from light.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.